These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 9514827
1. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL, Goadsby PJ. Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [Abstract] [Full Text] [Related]
3. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine? Goadsby PJ, Hoskin KL. Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840 [Abstract] [Full Text] [Related]
4. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Knight YE, Edvinsson L, Goadsby PJ. Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470 [Abstract] [Full Text] [Related]
5. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Goadsby PJ, Hoskin KL. Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929 [Abstract] [Full Text] [Related]
6. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors. Goadsby PJ, Knight Y. Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509 [Abstract] [Full Text] [Related]
7. [Mechanism of action of zolmitriptan]. Pascual J. Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690 [Abstract] [Full Text] [Related]
8. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Goadsby PJ, Knight YE. Cephalalgia; 1997 May; 17(3):153-8. PubMed ID: 9170337 [Abstract] [Full Text] [Related]
9. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Knight YE, Classey JD, Lasalandra MP, Akerman S, Kowacs F, Hoskin KL, Goadsby PJ. Brain Res; 2005 May 31; 1045(1-2):1-11. PubMed ID: 15910757 [Abstract] [Full Text] [Related]
11. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Martin GR. Cephalalgia; 1997 Oct 31; 17 Suppl 18():4-14. PubMed ID: 9399012 [Abstract] [Full Text] [Related]
16. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Hoskin KL, Kaube H, Goadsby PJ. Brain; 1996 Feb 31; 119 ( Pt 1)():249-56. PubMed ID: 8624686 [Abstract] [Full Text] [Related]
17. Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat. Pagniez F, Valentin JP, Vieu S, Colpaert FC, John GW. Br J Pharmacol; 1998 Jan 31; 123(2):205-14. PubMed ID: 9489607 [Abstract] [Full Text] [Related]
18. Effects of sumatriptan on rat medullary dorsal horn neurons. Jennings EA, Ryan RM, Christie MJ. Pain; 2004 Sep 31; 111(1-2):30-7. PubMed ID: 15327806 [Abstract] [Full Text] [Related]
19. 5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis. Mitsikostas DD, Sanchez del Rio M, Waeber C. Cephalalgia; 2002 Jun 31; 22(5):384-94. PubMed ID: 12110114 [Abstract] [Full Text] [Related]